Analyst Ratings for MEI Pharma (MEIP)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 3.3 / 10
Percentile Rank: 30%
Rating Score: 3.3 / 10
Percentile Rank: 30%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/23/2024 | Laidlaw | Yale Jen | Downgrade | Hold (Buy) |
N/A (N/A) |
2.86 (3.07) |
7.34% | Details |
| 7/22/2024 | Brookline Capital Markets | Leah Rush Cann | Downgrade | Hold (Buy) |
N/A (N/A) |
2.86 (3.07) |
7.34% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
